Raymond James & Associates’s DocGo DCGO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q3
$518K Buy
155,892
+34,579
+29% +$118K ﹤0.01% 3092
2024
Q2
$375K Buy
121,313
+10,535
+10% +$34.7K ﹤0.01% 3243
2024
Q1
$448K Sell
110,778
-68,430
-38% -$258K ﹤0.01% 3122
2023
Q4
$1M Buy
179,208
+28,734
+19% +$165K ﹤0.01% 2519
2023
Q3
$802K Buy
+150,474
New +$1.22M ﹤0.01% 2602

Other funds holding DCGO

Raymond James & Associates's DCGO Position: Q3 2024 in Review

Raymond James & Associates increased its DocGo (DCGO) stake by 29% in Q3 2024, buying an estimated $118K and bringing the position to 155,892 shares worth $518K. The position accounts for ﹤0.01% of the portfolio, ranked #3092.

Raymond James & Associates first reported a position in DCGO in Q3 2023 and has held it in 5 quarters since. The position peaked at $1M in Q4 2023. 126 funds tracked by Wall St. Rank hold DCGO as of Q3 2024.

  • Raymond James & Associates held 155,892 shares of DocGo worth $518K as of Q3 2024.
  • Raymond James & Associates bought 34,579 DocGo shares in Q3 2024, an estimated $118K.
  • DocGo made up ﹤0.01% of Raymond James & Associates's portfolio in Q3 2024, its #3092 holding.
  • Raymond James & Associates first reported a position in DocGo in Q3 2023 and has held it in 5 quarters since.
  • Raymond James & Associates's DocGo position peaked at $1M in Q4 2023.
  • 126 funds tracked by Wall St. Rank held DocGo as of Q3 2024.

Based on Raymond James & Associates's 13F filing for Q3 2024, filed 18 Oct 2024.